Sign In
Buy DCTH
$10.33
-0.200 (-1.90%)
At Close: Jun 03, 2026
Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
07:30am, Monday, 09'th Aug 2021
NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, anno
Delcath Systems to Present at Upcoming Virtual Investor Conferences
09:00am, Thursday, 05'th Aug 2021
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, anno
Will Delcath Systems, Inc. (DCTH) Report Negative Earnings Next Week? What You Should Know
04:47pm, Tuesday, 03'rd Aug 2021
Delcath Systems, Inc. (DCTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Delcath Systems: Ready To Return To A Previous Winner
07:48pm, Tuesday, 22'nd Jun 2021
Delcath Systems is moving closer to submitting their NDA for their drug/device kit of melphalan hydrochloride with hepatic delivery system, HEPZATO. If approved, Delcath would have several. HEPZATO ha
Delcath Systems' Hepzato Achieves 44% Best Overall Response Compared to Best Alternative Care in Eye Cancer
12:21pm, Monday, 07'th Jun 2021
Delcath Systems Inc (NASDAQ: DCTH) has announced positive preliminary efficacy results from its FOCUS Phase 3 trial evaluating Hepzato Kit (melphalan hydrochloride for injection/hepatic delivery sy
Positive Preliminary Results from Delcath Systems' FOCUS Trial Presented at the 2021 ASCO Annual Meeting
07:30am, Monday, 07'th Jun 2021
As Previously Disclosed, the Prespecified Primary Endpoint, Objective Response Rate, Has Been Met by Exceeding the 95% CI Lower Bound Threshold for Success
Moving Average Crossover Alert: Delcath Systems (DCTH)
07:31am, Monday, 24'th May 2021
Delcath Systems (DCTH) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q1 2021 Results - Earnings Call Transcript
01:56pm, Tuesday, 11'th May 2021
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q1 2021 Results - Earnings Call Transcript
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Tops Revenue Estimates
10:31am, Tuesday, 11'th May 2021
Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -16.85% and 3.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Delcath Systems, Inc. Announces First Quarter 2021 Results
08:00am, Tuesday, 11'th May 2021
NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today repor
Delcath Systems Schedules Conference Call to Report 2021 First Quarter Financial Results
04:01pm, Friday, 30'th Apr 2021
NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, ann
Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom
08:38am, Wednesday, 21'st Apr 2021
Recommends Special Arrangement Designation Which Increases Reimbursement Options Recommends Special Arrangement Designation Which Increases Reimbursement Options
Delcath Systems, Inc. Shares Additional Information Regarding FOCUS Trial Power Calculation
02:55pm, Wednesday, 31'st Mar 2021
20.1% Lower Bound of Preliminary ORR Analysis Exceeds Required 8.3% Threshold 20.1% Lower Bound of Preliminary ORR Analysis Exceeds Required 8.3% Threshold
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q4 2020 Results - Earnings Call Transcript
01:59pm, Wednesday, 31'st Mar 2021
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q4 2020 Results - Earnings Call Transcript
DCTH Stock Price Fell Over 30% Pre-Market: Why It Happened
08:24am, Wednesday, 31'st Mar 2021
The stock price of Delcath Systems, Inc. (NASDAQ: DCTH) fell by over 30% pre-market. This is why it happened.
